Chicago Equity Partners’s Teradyne TER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$1.99M Sell
36,710
-1,220
-3% -$77.4K 0.2% 140
2019
Q4
$2.59M Sell
37,930
-2,715
-7% -$172K 0.15% 203
2019
Q3
$2.35M Sell
40,645
-8,800
-18% -$466K 0.11% 273
2019
Q2
$2.37M Buy
49,445
+2,430
+5% +$110K 0.11% 280
2019
Q1
$1.87M Sell
47,015
-21,650
-32% -$809K 0.07% 357
2018
Q4
$2.15M Sell
68,665
-8,225
-11% -$279K 0.09% 323
2018
Q3
$2.84M Buy
76,890
+59,125
+333% +$2.38M 0.08% 317
2018
Q2
$676K Sell
17,765
-59,055
-77% -$2.3M 0.02% 595
2018
Q1
$3.51M Buy
76,820
+265
+0.3% +$12.1K 0.11% 260
2017
Q4
$3.21M Buy
76,555
+25,695
+51% +$1.06M 0.1% 268
2017
Q3
$1.9M Sell
50,860
-14,820
-23% -$513K 0.06% 379
2017
Q2
$1.97M Buy
65,680
+47,930
+270% +$1.61M 0.05% 373
2017
Q1
$552K Buy
+17,750
New +$507K 0.02% 571
2016
Q2
Sell
-67,955
Closed -$1.47M 690
2016
Q1
$1.47M Buy
67,955
+50,450
+288% +$987K 0.04% 300
2015
Q4
$362K Buy
+17,505
New +$348K 0.01% 517

Other funds holding TER

Chicago Equity Partners's TER Position: Q1 2020 in Review

Chicago Equity Partners reduced its Teradyne (TER) stake by 3.2% in Q1 2020, selling an estimated $77.4K and leaving 36,710 shares worth $1.99M. The position accounts for 0.2% of the portfolio, ranked #140.

Chicago Equity Partners first reported a position in TER in Q4 2015 and has held it in 15 quarters since. The position peaked at $3.51M in Q1 2018. 495 funds tracked by Wall St. Rank hold TER as of Q1 2020.

  • Chicago Equity Partners held 36,710 shares of Teradyne worth $1.99M as of Q1 2020.
  • Chicago Equity Partners sold 1,220 Teradyne shares in Q1 2020, an estimated $77.4K.
  • Teradyne made up 0.2% of Chicago Equity Partners's portfolio in Q1 2020, its #140 holding.
  • Chicago Equity Partners first reported a position in Teradyne in Q4 2015 and has held it in 15 quarters since.
  • Chicago Equity Partners's Teradyne position peaked at $3.51M in Q1 2018.
  • 495 funds tracked by Wall St. Rank held Teradyne as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.